Similar articles for PMID: 14726404

Year	Number of Results
1930	1
1997	1
1999	4
2000	6
2001	10
2002	10
2003	11
2004	17
2005	23
2006	8
2007	2
2008	6
2009	2
2010	3
2011	4
2012	2
2013	7
2014	3
2016	1
2019	4
2020	3
2021	3
2022	2
2023	5
2024	0

1

IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells.

Tecchio C, Huber V, Scapini P, Calzetti F, Margotto D, Todeschini G, Pilla L, Martinelli G, Pizzolo G, Rivoltini L, Cassatella MA. Tecchio C, et al. Blood. 2004 May 15;103(10):3837-44. doi: 10.1182/blood-2003-08-2806. Epub 2004 Jan 15. Blood. 2004. PMID: 14726404 Free article.

2

Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients.

Tanaka H, Ito T, Kyo T, Kimura A. Tanaka H, et al. Eur J Haematol. 2007 May;78(5):389-98. doi: 10.1111/j.1600-0609.2007.00834.x. Eur J Haematol. 2007. PMID: 17432976

3

Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.

Yamamoto T, Nagano H, Sakon M, Wada H, Eguchi H, Kondo M, Damdinsuren B, Ota H, Nakamura M, Wada H, Marubashi S, Miyamoto A, Dono K, Umeshita K, Nakamori S, Yagita H, Monden M. Yamamoto T, et al. Clin Cancer Res. 2004 Dec 1;10(23):7884-95. doi: 10.1158/1078-0432.CCR-04-0794. Clin Cancer Res. 2004. PMID: 15585621

4

Absence of gene mutation in TRAIL receptor 1 (TRAIL-R1) and TRAIL receptor 2 (TRAIL-R2) in chronic myelogenous leukemia and myelodysplastic syndrome, and analysis of mRNA Expressions of TRAIL and TRAIL-related genes in chronic myelogenous leukemia.

Liu LG, Tanaka H, Ito K, Ito T, Sultana TA, Kyo T, Kimura A. Liu LG, et al. Acta Haematol. 2005;113(2):113-23. doi: 10.1159/000083449. Acta Haematol. 2005. PMID: 15802890

5

Increased expression and release of functional tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by T cells from lupus patients with active disease.

Rus V, Zernetkina V, Puliaev R, Cudrici C, Mathai S, Via CS. Rus V, et al. Clin Immunol. 2005 Oct;117(1):48-56. doi: 10.1016/j.clim.2005.05.001. Clin Immunol. 2005. PMID: 15961346

6

Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils.

Kamohara H, Matsuyama W, Shimozato O, Abe K, Galligan C, Hashimoto S, Matsushima K, Yoshimura T. Kamohara H, et al. Immunology. 2004 Feb;111(2):186-94. doi: 10.1111/j.0019-2805.2003.01794.x. Immunology. 2004. PMID: 15027904 Free PMC article.

7

Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators.

Cassatella MA, Huber V, Calzetti F, Margotto D, Tamassia N, Peri G, Mantovani A, Rivoltini L, Tecchio C. Cassatella MA, et al. J Leukoc Biol. 2006 Jan;79(1):123-32. doi: 10.1189/jlb.0805431. Epub 2005 Oct 21. J Leukoc Biol. 2006. PMID: 16244105

8

The tumor necrosis factor-related apoptosis-inducing ligand receptors TRAIL-R1 and TRAIL-R2 have distinct cross-linking requirements for initiation of apoptosis and are non-redundant in JNK activation.

Mühlenbeck F, Schneider P, Bodmer JL, Schwenzer R, Hauser A, Schubert G, Scheurich P, Moosmayer D, Tschopp J, Wajant H. Mühlenbeck F, et al. J Biol Chem. 2000 Oct 13;275(41):32208-13. doi: 10.1074/jbc.M000482200. J Biol Chem. 2000. PMID: 10807904 Free article.

9

Plasmacytoid dendritic cell-derived IFN-alpha induces TNF-related apoptosis-inducing ligand/Apo-2L-mediated antitumor activity by human monocytes following CpG oligodeoxynucleotide stimulation.

Kemp TJ, Elzey BD, Griffith TS. Kemp TJ, et al. J Immunol. 2003 Jul 1;171(1):212-8. doi: 10.4049/jimmunol.171.1.212. J Immunol. 2003. PMID: 12817000

10

Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L.

Kemp TJ, Ludwig AT, Earel JK, Moore JM, Vanoosten RL, Moses B, Leidal K, Nauseef WM, Griffith TS. Kemp TJ, et al. Blood. 2005 Nov 15;106(10):3474-82. doi: 10.1182/blood-2005-03-1327. Epub 2005 Jul 21. Blood. 2005. PMID: 16037389 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

125 results

Results by year